Can a drug that relaxes blood vessels help Black adults with obesity?
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether a medication that helps relax blood vessels can improve heart and metabolic health in Black adults with obesity and early signs of insulin resistance. It may help lower blood pressure and reduce risk of heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be Black or African American.
- You must be 18 or older.
- Your BMI (a measure of weight and height) must be 30 to 45.
- You must have a sign of insulin resistance (HOMA-IR ≥ 2.5).
- Your blood pressure should be between 120-160/80-100 mmHg (if not on meds or after a 1-week break from up to 2 types of blood pressure meds).
- You cannot have diabetes, heart disease, serious kidney disease, or certain other medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a natriuretic peptide medicine improves heart health and metabolism in Black adults. It may help with blood pressure and related health markers, but you must meet specific health and safety criteria.
This trial tests whether an SGLT2 inhibitor (a type of diabetes medication) can help reduce stiffness in the arteries of veterans who have obesity. If you are a veteran aged 30-60 with a BMI of 30-45 and have stiffer arteries than expected for your age, this study might be an option.
This trial looks at how weight loss changes tiny particles released from fat cells and whether that improves blood vessel function. It may help understand how losing weight can protect your heart.
This study tests if giving small rewards for buying healthy food and taking medicines can lower heart disease risk in African American adults who have trouble getting enough food. You will get help with food costs and health coaching.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This early-stage study tests whether vitamin C (and possibly how your body uses it) affects blood vessel function in people with obesity and insulin resistance. You may be asked to stop certain supplements before starting so researchers can measure the effect more clearly.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.